Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence.
Yahya A MohzariAhmed A AlamerMajda AlattasAhmed A AlrashedNura A AlshehabTurkiah K AlkhaldiAmnah A AlamerSyed Mohammed Basheeruddin AsdaqDoaa AljefriHamdan N AlajamiYazed Saleh AlsowaidaMaya MathewMohammed I AlMusawaMukhtar AlomarRaghad Y AlharbiMalik KhuwajaReem F BamogaddamAshwaq H AlharthiAisha Y FaqihiBashayer F AlrumayyanAbeer AlshareefBatool M AlhassanNader Y DamfuGhada S AlajmiAsma AlbujaidyMaram AlghalbiSaleh A AlajlanIvo AbrahamAbdulaziz Saleh AlmulhimPublished in: Expert review of anti-infective therapy (2022)
Although tocilizumab was not found to be effective in reducing mortality, extubation rate while on mechanical ventilation was higher among tocilizumab treated group.
Keyphrases
- mechanical ventilation
- acute respiratory distress syndrome
- rheumatoid arthritis
- intensive care unit
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- respiratory failure
- extracorporeal membrane oxygenation
- randomized controlled trial
- disease activity
- sars cov
- systematic review
- cardiovascular events
- type diabetes
- cardiac surgery
- cross sectional
- systemic lupus erythematosus
- acute kidney injury